Onderneming Phytopharm plc London S.E.
Aandelen
GB0006869720
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- GBX | - |
Vakgebied
Verkoop per activiteit
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Clinical Trials Services
100,0
%
| 9 | 100,0 % | 7 | 100,0 % | -22,89% |
Verkoop per regio
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
45,8
%
| 3 | 31,4 % | 3 | 45,8 % | +12,62% |
United Kingdom
14,3
%
| 2 | 23,8 % | 1 | 14,3 % | -53,72% |
Netherlands
12,9
%
| 0 | 5,0 % | 1 | 12,9 % | +97,71% |
Switzerland
12,2
%
| 2 | 24,0 % | 1 | 12,2 % | -60,71% |
Ireland
10,3
%
| 1 | 8,4 % | 1 | 10,3 % | -4,83% |
Europe
4,4
%
| 1 | 7,4 % | 0 | 4,4 % | -54,08% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Giulio Cerroni
CEO | Chief Executive Officer | 63 | 06-02-17 |
Director of Finance/CFO | 47 | 31-05-19 | |
Charles Spicer
CHM | Chairman | 59 | 14-10-13 |
Romina Oxborough
COO | Chief Operating Officer | - | - |
Robin Wolz
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Michelle Lax
CTO | Chief Tech/Sci/R&D Officer | 45 | 01-01-12 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Charles Spicer
CHM | Chairman | 59 | 14-10-13 |
Director/Board Member | 49 | 16-09-16 | |
Dipti Amin
BRD | Director/Board Member | 60 | 05-10-23 |
Giulio Cerroni
CEO | Chief Executive Officer | 63 | 06-02-17 |
Director of Finance/CFO | 47 | 31-05-19 | |
Director/Board Member | 57 | 21-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 48 351 373 | 24 741 986 ( 51,17 %) | 0 | 51,17 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,56% | 46,71 mld. | |
-1,51% | 41,52 mld. | |
+48,83% | 41,8 mld. | |
-3,42% | 29,55 mld. | |
+10,13% | 25,78 mld. | |
-20,44% | 19,26 mld. | |
+26,45% | 11,98 mld. | |
-0,14% | 12,14 mld. | |
-0,47% | 12,08 mld. |